Małgorzata Szeląg

803 total citations
20 papers, 655 citations indexed

About

Małgorzata Szeląg is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Małgorzata Szeląg has authored 20 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Małgorzata Szeląg's work include Cytokine Signaling Pathways and Interactions (7 papers), Free Radicals and Antioxidants (7 papers) and interferon and immune responses (3 papers). Małgorzata Szeląg is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), Free Radicals and Antioxidants (7 papers) and interferon and immune responses (3 papers). Małgorzata Szeląg collaborates with scholars based in Poland, France and Netherlands. Małgorzata Szeląg's co-authors include Marcin Molski, Alicja Urbaniak, Hans A.R. Bluyssen, Joanna Wesoły, Damian Mikulski, Anna Czerwoniec, Ewa D. Raczyńska, Pierre‐Charles Maria, Zbigniew Kwias and Rachel H. Giles and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and European Journal of Pharmacology.

In The Last Decade

Małgorzata Szeląg

20 papers receiving 647 citations

Peers

Countries citing papers authored by Małgorzata Szeląg

Since Specialization

Citations

This map shows the geographic impact of Małgorzata Szeląg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Szeląg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Szeląg more than expected).

Fields of papers citing papers by Małgorzata Szeląg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Szeląg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Szeląg. The network helps show where Małgorzata Szeląg may publish in the future.

Co-authorship network of co-authors of Małgorzata Szeląg

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Szeląg. A scholar is included among the top collaborators of Małgorzata Szeląg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Szeląg. Małgorzata Szeląg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs 2018 ·Frontiers in Immunology ·(unknown), Małgorzata Szeląg, Aida Collado, Patrice Marqués, Susana Vallejo, (unknown), Joanna Wesoły, María‐Jesús Sanz, Concepción Peiró, Hans A.R. Bluyssen	12
2	Antioxidant properties of several caffeic acid derivatives: A theoretical study 2017 ·Comptes Rendus Chimie ·Alicja Urbaniak, Jacek Kujawski, (unknown), Małgorzata Szeląg	25
3	Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases 2016 ·Current Protein and Peptide Science ·Małgorzata Szeląg, Joanna Wesoły, Hans A.R. Bluyssen	10
4	Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease 2016 ·Oncotarget ·Małgorzata Szeląg, (unknown), (unknown), Joanna Wesoły, Hans A.R. Bluyssen	53
5	Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors 2015 ·BMC Cancer ·Tomasz Wrzesiński, Małgorzata Szeląg, (unknown), (unknown), Rachel H. Giles, (unknown), (unknown), Joanna Poźniak, Zbigniew Kwias, Hans A.R. Bluyssen, Joanna Wesoły	83
6	Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation 2015 ·PLoS ONE ·Małgorzata Szeląg, Anna Czerwoniec, Joanna Wesoły, Hans A.R. Bluyssen	30
7	CAVS—Novel in silico selection strategy of specific STAT inhibitory compounds 2015 ·Journal of Computational Science ·Anna Czerwoniec, Małgorzata Szeląg, Kajetan Juszczak, Joanna Wesoły, Hans A.R. Bluyssen	6
8	Comparative screening and validation as a novel tool to identify STAT-specific inhibitors 2014 ·European Journal of Pharmacology ·Małgorzata Szeląg, Anna Czerwoniec, Joanna Wesoły, Hans A.R. Bluyssen	8
9	A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids 2014 ·Open Chemistry ·Małgorzata Szeląg, Alicja Urbaniak, Hans A.R. Bluyssen	38
10	Low-molecular weight organic acids and peptides involved in the long-distance transport of trace metals 2014 ·Acta Physiologiae Plantarum ·(unknown), Małgorzata Szeląg	64
11	In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity 2013 ·European Journal of Pharmacology ·Małgorzata Szeląg, K. Sikorski, Anna Czerwoniec, (unknown), Joanna Wesoły, Hans A.R. Bluyssen	26
12	Theoretical investigation of stereochemistry and solvent influence on antioxidant activity of ferulic acid 2013 ·Computational and Theoretical Chemistry ·Alicja Urbaniak, Małgorzata Szeląg, Marcin Molski	82
13	Quantum-chemical Calculations of the Antioxidant Properties of trans-p-coumaric Acid and trans-sinapinic Acid 2012 ·Computational Methods in Science and Technology ·Alicja Urbaniak, Marcin Molski, Małgorzata Szeląg	42
14	Quantum-chemical study of interactions of trans-resveratrol with guanine-thymine dinucleotide and DNA-nucleobases 2011 ·Journal of Molecular Modeling ·Damian Mikulski, Małgorzata Szeląg, Marcin Molski	2
15	Quantum-chemical investigation of the structure and the antioxidant properties of α-lipoic acid and its metabolites 2011 ·Journal of Molecular Modeling ·Małgorzata Szeląg, Damian Mikulski, Marcin Molski	79
16	Quantum-chemical study on the antioxidation mechanisms of trans-resveratrol reactions with free radicals in the gas phase, water and ethanol environment 2010 ·Journal of Molecular Structure THEOCHEM ·Damian Mikulski, Małgorzata Szeląg, Marcin Molski, (unknown)	34
17	Importance of CH tautomers in the tautomeric mixture of uric acid 2010 ·Journal of Molecular Structure THEOCHEM ·Ewa D. Raczyńska, Mariusz Makowski, Małgorzata Szeląg, (unknown), Katarzyna Zientara‐Rytter	13
18	Proton Transfer Chemistry in the Gas Phase. Is a Spontaneous 'Neutralization' Reaction a Myth or a Reality? 2009 ·Croatica Chemica Acta ·Ewa D. Raczyńska, Jean‐François Gal, Pierre‐Charles Maria, Małgorzata Szeląg	16
19	Application of FT-ICR-MS for the study of proton-transfer reactions involving biomolecules 2007 ·Analytical and Bioanalytical Chemistry ·Ewa D. Raczyńska, J.‐F. Gal, Pierre‐Charles Maria, Katarzyna Zientara‐Rytter, Małgorzata Szeląg	18
20	Salivary aldehyde dehydrogenase—Reversible oxidation of the enzyme and its inhibition by caffeine, investigated using fluorimetric method 2007 ·Archives of Oral Biology ·Jacek Wierzchowski, Monika Pietrzak, Małgorzata Szeląg, Piotr Wroczyński	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact